Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Szeinbach

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Clinical Pharmacy and Therapeutics|August 1, 1990
Factors influencing pharmacists' participation in third-party programmesS L Szeinbach
Medical Interface|December 9, 1993
Image development for health care firmsS L Szeinbach
American Journal of Hospital Pharmacy|June 1, 1992
Matrix management in hospital pharmacy departmentsS L Szeinbach
Clinical Therapeutics|March 1, 1993
Formularies: the role of pharmacy-and-therapeutics (P&T) committeesK H Summers, S L Szeinbach
Topics in Hospital Pharmacy Management|June 7, 1992
An examination of adverse drug event monitoring practices in U.S. hospitalsJ P Juergens, S L Szeinbach
American Pharmacy|March 1, 1994
Biotech products pose distribution challengesS L Szeinbach, E L Gillenwater
Hospital Pharmacy|December 11, 1984
Lawful uses of drugs purchased at preferential pricesS L Szeinbach, J L Fink
Medical Interface|January 8, 1995
Creating a managed care service networkS L Szeinbach, J E Horine
American Pharmacy|September 1, 1984
Identifying the pharmacist's professional statusS L Szeinbach, J L Fink
Journal of Applied Toxicology : JAT|December 1, 1983
The genetic activity of anthramycin, tomaymycin and sibiromycin in bacterial forward- and reverse-mutation assays and in the mouse bone-marrow micronucleus testC Gairola, H Thomas, S L Szeinbach, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pharmacy and Therapeutics|August 1, 1990
Factors influencing pharmacists' participation in third-party programmesS L Szeinbach
Medical Interface|December 9, 1993
Image development for health care firmsS L Szeinbach
American Journal of Hospital Pharmacy|June 1, 1992
Matrix management in hospital pharmacy departmentsS L Szeinbach
Clinical Therapeutics|March 1, 1993
Formularies: the role of pharmacy-and-therapeutics (P&T) committeesK H Summers, S L Szeinbach
Topics in Hospital Pharmacy Management|June 7, 1992
An examination of adverse drug event monitoring practices in U.S. hospitalsJ P Juergens, S L Szeinbach
American Pharmacy|March 1, 1994
Biotech products pose distribution challengesS L Szeinbach, E L Gillenwater
Hospital Pharmacy|December 11, 1984
Lawful uses of drugs purchased at preferential pricesS L Szeinbach, J L Fink
Medical Interface|January 8, 1995
Creating a managed care service networkS L Szeinbach, J E Horine
American Pharmacy|September 1, 1984
Identifying the pharmacist's professional statusS L Szeinbach, J L Fink
Journal of Applied Toxicology : JAT|December 1, 1983
The genetic activity of anthramycin, tomaymycin and sibiromycin in bacterial forward- and reverse-mutation assays and in the mouse bone-marrow micronucleus testC Gairola, H Thomas, S L Szeinbach, et al.
Pageof 3